AI

Arpit Indravadanbhai Shah

Active Director Director/Designated Partner DIN 11890049
DIN 11890049 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Arpit Indravadanbhai Shah

Arpit Indravadanbhai Shah is a Director/Designated Partner at Optalogic Pharma Private Limited (since 2026).

DIN 11890049
Primary Designation Director/Designated Partner
First Appointment 14 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Optalogic Pharma Private Limited U46497GJ2026PTC182339
Director/Designated Partner14 Aug 20262026Active

Board colleagues of Arpit Indravadanbhai Shah

NameDINCompanyDesignation
Sunilkumar Rajubhai Dhanani11890050Optalogic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Optalogic Pharma Private Limited
Premium access

Shareholding and investment profile for Arpit Indravadanbhai Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpit Indravadanbhai Shah

Arpit Indravadanbhai Shah currently holds 1 directorship: Optalogic Pharma Private Limited (Director/Designated Partner, since 14 Aug 2026).

Arpit Indravadanbhai Shah was first appointed on 14 Aug 2026 as Director/Designated Partner at Optalogic Pharma Private Limited.

The current boards of Arpit Indravadanbhai Shah's companies include Sunilkumar Rajubhai Dhanani (Optalogic Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available